Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 | P29475 | 2/20 | 0.43 |
| ▸ | NOS3 | P29474 | 1/20 | 0.43 |
| ▸ | NOS2 | P35228 | 1/20 | 0.43 |
| ▸ | CTSS | P25774 | 1/20 | 0.41 |
| ▸ | CTSK | P43235 | 1/20 | 0.41 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.37 |
| ▸ | LTA4H | P09960 | 1/20 | 0.37 |
| ▸ | METAP2 | P50579 | 1/20 | 0.37 |
| ▸ | METAP1 | P53582 | 1/20 | 0.37 |
| ▸ | MARS1 | P56192 | 5/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | ANPEP | P15144 | 1/20 | 0.35 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.35 |
| ▸ | BHMT | Q93088 | 3/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11119448 | 1.00 | NOS1 (0.43) | NOS1NOS3NOS2CTSSCTSK | |
| SCHEMBL7157725 | 1.00 | NOS1 (0.43) | NOS1NOS3NOS2CTSSCTSK | |
| Hydrochloric Acid SCHEMBL918798 | 0.98 | NOS1 (0.42) | NOS1NOS3NOS2CTSSCTSK | |
| Hydrochloric Acid SCHEMBL5211496 | 0.98 | NOS1 (0.42) | NOS1NOS3NOS2CTSSCTSK | |
| SCHEMBL27863494 | 0.89 | NOS1 (0.41) | NOS1NOS3NOS2CTSSCTSK | |
| SCHEMBL16618514 | 0.86 | CTSS (0.38) | NOS1NOS3NOS2CTSSCTSK | |
| SCHEMBL3294154 | 0.84 | NOS1 (0.42) | NOS1NOS3NOS2CTSKLTA4H | |
| SCHEMBL10683562 | 0.84 | NOS1 (0.42) | NOS1NOS3NOS2LTA4HMETAP2 | |
| SCHEMBL24786178 | 0.83 | METAP2 (0.34) | CTSSCTSKRNPEPMETAP2METAP1 | |
| SCHEMBL918772 | 0.82 | NOS1 (0.43) | NOS1NOS3NOS2CTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1301660-C | Method for supplying bioavailable methionine to cow | AVENTIS ANIMAL NUTRITION SA (IE) | 2007-02-28 | — | — | CN | claimed |
| CN-1326322-A | Method for supplying bioavailable methionine to cow | AVENTIS ANIMAL NUTRITION SA (FR) | 2001-12-12 | — | — | CN | claimed |
| EP-4306530-B1 | SILANE-CONTAINING CONDENSED CYCLIC DIPEPTIDE COMPOUND, PRODUCTION METHOD THEREFOR, AND METHOD FOR PRODUCING POLYPEPTIDE COMPOUND USING SAME | CHUBU UNIV EDUCATIONAL FOUNDATION (JP) | 2026-04-01 | — | — | EP | disclosed |
| US-20250375544-A1 | DUAL MODE RADIOTRACER AND -THERAPEUTICS | UNIV MUENCHEN TECH (DE) | 2025-12-11 | — | — | US | disclosed |
| EP-4538279-A2 | REACTION AGENT FOR AMIDE REACTIONS AND AMIDE COMPOUND PRODUCTION METHOD USING SAME | Chubu University Educational Foundation (JP) | 2025-04-16 | — | — | EP | disclosed |
| US-20240209020-A1 | REACTION AGENT FOR AMIDE REACTION AND METHOD FOR PRODUCING AMIDE COMPOUND USING SAME | CHUBU UNIVERSITY EDUCATIONAL FOUNDATION (JP) | 2024-06-27 | — | — | US | disclosed |
| US-20240182517-A1 | SILANE-CONTAINING CONDENSED CYCLIC DIPEPTIDE COMPOUND, PRODUCTION METHOD THEREFOR, AND METHOD FOR PRODUCING POLYPEPTIDE COMPOUND USING SAME | CHUBU UNIVERSITY EDUCATIONAL FOUNDATION (JP) | 2024-06-06 | — | — | US | disclosed |
| EP-4306530-A1 | SILANE-CONTAINING CONDENSED CYCLIC DIPEPTIDE COMPOUND, PRODUCTION METHOD THEREFOR, AND METHOD FOR PRODUCING POLYPEPTIDE COMPOUND USING SAME | Chubu University Educational Foundation (JP) | 2024-01-17 | — | — | EP | disclosed |
| EP-4271422-A1 | DUAL MODE RADIOTRACER AND -THERAPEUTICS | Technische Universität München (DE) | 2023-11-08 | — | — | EP | disclosed |
| CN-116981486-A | Dual mode radiotracer and therapeutic agent | 慕尼黑工业大学 | 2023-10-31 | — | — | CN | disclosed |
| EP-3334710-B1 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING NEURODEGENERATIVE DISORDERS | ALZHEON INC (US) | 2023-10-04 | — | — | EP | disclosed |
| WO-1998032741-A1 | INHIBITORS OF FARNESYL PROTEIN TRANSFERASE | ZENECA LIMITED (GB) | 1998-07-30 | — | — | WO | disclosed |
| US-5786480-A | ANTITUMOR AGENT; VIRICIDES | SCHERING CORPORATION (US) | 1998-07-28 | — | — | US | disclosed |
| WO-1998011073-A1 | 8-HYDROXY-7-SUBSTITUTED QUINOLINES AS ANTI-VIRAL AGENTS | PHARMACIA & UPJOHN COMPANY (US) | 1998-03-19 | — | — | WO | disclosed |
| WO-1998007713-A1 | HIGH MOLECULAR WEIGHT POLYMER-BASED PRODRUGS | ENZON, INC. (US) | 1998-02-26 | — | — | WO | disclosed |
| EP-0750609-A4 | ISOPRENYL TRANSFERASE INHIBITORS | EISAI CO LTD (JP) | 1997-09-24 | — | — | EP | disclosed |
| US-5608067-A | ANTITUMOR AGENTS | MERCK SHARP & DOHME CORP. | 1997-03-04 | — | — | US | disclosed |
| EP-0750609-A1 | ISOPRENYL TRANSFERASE INHIBITORS | Eisai Co., Ltd. (JP) | 1997-01-02 | — | — | EP | disclosed |
| WO-1995025086-A1 | ISOPRENYL TRANSFERASE INHIBITORS | EISAI CO., LTD. (JP) | 1995-09-21 | — | — | WO | disclosed |
| EP-0618221-A2 | Heterocyclic inhibitors of farnesyl protein transferase | BRISTOL-MYERS SQUIBB COMPANY (US) | 1994-10-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250375544-A1 | DUAL MODE RADIOTRACER AND -THERAPEUTICS | MAN2B1, GBA1, SSTR1 | NOS1 3459/4885NOS3 4753/4885NOS2 4741/4885 |
| US-20240209020-A1 | REACTION AGENT FOR AMIDE REACTION AND METHOD FOR PRODUCING AMIDE COMPOUND USING SAME | NAAA, FAAH, FAAH2 | NOS1 365/4885NOS3 1587/4885NOS2 626/4885 |
| US-20240182517-A1 | SILANE-CONTAINING CONDENSED CYCLIC DIPEPTIDE COMPOUND, PRODUCTION METHOD THEREFOR, AND METHOD FOR PRODUCING POLYPEPTIDE COMPOUND USING SAME | VIP, NGLY1, NPR1 | NOS1 186/4885NOS3 796/4885NOS2 262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.